Green Cross, Daewoong Diverge In Global Expansion Push

Two leading South Korean pharma firms are moving in different directions as they aim to expand globally, with Daewoong Pharm agreeing to buy a controlling stake in HanAll BioPharma, while Green Cross has divested its entire stake in Ildong Pharm.

More from South Korea

More from Focus On Asia